Harvard Bioscience, Inc.HBIONASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year revenue growth rate
Latest
0.69%
↑ 153408% above average
Average (39q)
0.00%
Historical baseline
Range
High:28.90%
Low:-23.25%
CAGR
-6.7%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | 0.69% |
| Q2 2025 | -6.08% |
| Q1 2025 | -11.33% |
| Q4 2024 | 11.77% |
| Q3 2024 | -4.88% |
| Q2 2024 | -5.77% |
| Q1 2024 | -12.93% |
| Q4 2023 | 11.00% |
| Q3 2023 | -11.81% |
| Q2 2023 | -4.06% |
| Q1 2023 | 5.45% |
| Q4 2022 | 5.59% |
| Q3 2022 | -7.83% |
| Q2 2022 | 1.49% |
| Q1 2022 | -12.94% |
| Q4 2021 | 11.44% |
| Q3 2021 | 1.60% |
| Q2 2021 | 8.18% |
| Q1 2021 | -12.89% |
| Q4 2020 | 28.90% |
| Q3 2020 | 3.13% |
| Q2 2020 | -1.95% |
| Q1 2020 | -23.25% |
| Q4 2019 | 12.96% |
| Q3 2019 | -7.32% |
| Q2 2019 | 4.90% |
| Q1 2019 | -16.71% |
| Q4 2018 | 18.24% |
| Q3 2018 | -9.16% |
| Q2 2018 | 17.80% |
| Q1 2018 | -2.56% |
| Q4 2017 | 9.63% |
| Q3 2017 | -0.65% |
| Q2 2017 | 4.38% |
| Q1 2017 | -8.55% |
| Q4 2016 | 5.63% |
| Q3 2016 | -4.32% |
| Q2 2016 | -3.07% |
| Q1 2016 | -4.96% |
| Q4 2015 | 10.26% |